Compare BioNano Genomics Inc (BNGO) vs Virgin Galactic Holdings, Inc. (SPCE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Virgin Galactic Holdings, Inc. — how do they compare? BioNano Genomics Inc trades at $1.15 (market cap $13.48M), while Virgin Galactic Holdings, Inc. trades at $2.6 (market cap $311.06M). The key difference: Virgin Galactic Holdings, Inc. is far larger — about 23.1× BioNano Genomics Inc's market cap. Which is the better fit depends on your goals.
| BNGO | SPCE | |
|---|---|---|
Market Cap | $13.48M | $311.06M |
Sector | Health | Industrials |
52-Week High | $4.92 | $7.52 |
52-Week Low | $1.09 | $2.17 |
Enterprise Value | $16.09M | $410.91M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Virgin Galactic Holdings, Inc.
Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.
Read more on SPCE →
